Skip to content

Effects of vaginal erbium laser versus local estrogen for the treatment of genitourinary syndrome of menopause, a randomized controlled trial

Effects of vaginal erbium laser versus local estrogen for the treatment of genitourinary syndrome of menopause, a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200714006
Enrollment
98
Registered
2020-07-14
Start date
2020-08-11
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

&#45

Interventions

vaginal erbium laser for 10 minutes every 4 weeks for 3 times,1 tab vaginal suppo OD for 12 days&#44
then 2 tabs per week for total duration 12 weeks
vaginal erbium laser ,local estrogen plus probiotic

Sponsors

Ratchadapisek sompotch Fund
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Natural postmenopause women (more than 12 months of amenorrheic period without other related organic pathologies) 2. Age 45-75 years 3. Women presenting with at least one clinical symptom of genitourinary syndrome of menopause(vaginal dryness, dyspareunia, itching, irritation)

Exclusion criteria

Exclusion criteria: 1. Receive treatment with vaginal moisturizers, vaginal lubricant, vaginal laser, systemic or local estrogens within 90 days before recruitment 2. Pelvic organ prolapse stage 3 or higher 3. BMI of more than 35 kg/m2 4. Vaginal infection within 30 days 5. Any type of vaginal surgery within 90 days

Design outcomes

Primary

MeasureTime frame
Vaginal Maturation Index 4,8,112 weeks Vaginal Maturation Index

Secondary

MeasureTime frame
patient symptoms(dryness, dyspareunia, ithching, irritation) 12 weeks Visual analogue scale,patient satisfation 12 weeks Visual analogue scale,vaginal health index (VHI) 12 weeks clinical evaluation,adverse effects 12 weeks Bleeding, infection, pain incidence

Contacts

Public ContactKrasean Panyakamlerd

Chulalongkorn University

Dr.krasean.hotmail.com66926536415

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026